CFTR in K562 human leukemic cells

被引:9
|
作者
Assef, YA
Damiano, AE
Zotta, E
Ibarra, C
Kotsias, BA
机构
[1] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, Fac Med, RA-1427 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Dept Fisiol, Fac Med, RA-1427 Buenos Aires, DF, Argentina
来源
关键词
CFTR; K562; cells; leukemia cells; ion channels; glibenclamide; DIDS; PCR; immunohistochemistry;
D O I
10.1152/ajpcell.00320.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, the expression and functional characterization of CFTR ( cystic fibrosis transmembrane regulator) was determined in K562 chronic human leukemia cells. Expression of the CFTR gene product was determined by RT-PCR and confirmed by immunohistochemistry and Western blot analysis. Functional characterization of CFTR Cl- channel activity was conducted with patch-clamp techniques. Forskolin, an adenylyl cyclase activator, induced an anion-selective channel with a linear current-voltage relationship and a single-channel conductance of 11 pS. This cAMP-activated channel had a P-gluconate/P-Cl or P-F/P-Cl perm-selectivity ratio of 0.35 and 0.30, respectively, and was inhibited by the CFTR blocker glibenclamide and the anti-CFTR antibody MAb 13-1, when added to the cytoplasmatic side of the patch. Glibenclamide decreased the open probability increasing the frequency of open-to-closed transitions. Addition of 200 muM DIDS caused an irreversible block of the channels when added to the cytosolic side of inside-out patches. These and other observations indicate a widespread distribution of CFTR gene expression and suggest that this channel protein may function in most human cells to help maintain cellular homeostasis.
引用
收藏
页码:C480 / C488
页数:9
相关论文
共 50 条
  • [41] ENHANCEMENT BY HEMIN OF THE SENSITIVITY OF K562 HUMAN-LEUKEMIC CELLS TO 1-BETA-DEUTERIUM-ARABINOFURANOSYLCYTOSINE
    OKABEKADO, J
    HAYASHI, M
    HONMA, Y
    HOZUMI, M
    CANCER RESEARCH, 1986, 46 (03) : 1239 - 1243
  • [42] C/EBPα S248A mutation reduces granulocytic differentiation in human leukemic K562 cells
    Singh, Sheo M.
    Trivedi, A. K.
    Behre, Gerhard
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 369 (02) : 692 - 694
  • [43] Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol
    Cortesi, R
    Gui, V
    Osti, F
    Nastruzzi, C
    Gambari, R
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 61 (05) : 295 - 301
  • [44] THE EFFECT OF EDTA AND SERUM ON ENDOGENOUS PORPHYRIN ACCUMULATION AND PHOTODYNAMIC SENSITIZATION OF HUMAN K562 LEUKEMIC-CELLS
    HANANIA, J
    MALIK, Z
    CANCER LETTERS, 1992, 65 (02) : 127 - 131
  • [45] Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line
    Aydin, Banu
    Tulunay, Aysin
    Eksioglu-Demiralp, Emel
    Kan, Beki
    Cabadak, Hulya
    MARMARA MEDICAL JOURNAL, 2019, 32 (01): : 38 - 43
  • [46] Bortezomib induces apoptosis by interacting with JAK/STAT pathway in K562 leukemic cells
    Selvi, Nur
    Kaymaz, Burcin Tezcanli
    Gunduz, Cumhur
    Aktan, Cagdas
    Kiper, Hatice Demet
    Sahin, Fahri
    Comert, Melda
    Selvi, Ali Fatih
    Kosova, Buket
    Saydam, Guray
    TUMOR BIOLOGY, 2014, 35 (08) : 7861 - 7870
  • [47] Physical and functional association of cortactin with Syk in human leukemic cell line K562
    Maruyama, S
    Kurosaki, T
    Sada, K
    Yamanashi, Y
    Yamamoto, T
    Yamamura, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (12) : 6631 - 6635
  • [48] REGULATION OF HEMOGLOBIN ACCUMULATION IN THE K562 HUMAN-LEUKEMIC CELL-LINE
    DEAN, A
    ERARD, F
    SCHECHTER, AN
    CLINICAL RESEARCH, 1981, 29 (02): : A332 - A332
  • [49] Proteome analysis of chronic myelogenous leukemic K562 cells induced by harringtonine.
    Liu, XL
    Li, R
    Du, QF
    Zhou, SY
    Luo, RC
    BLOOD, 2002, 100 (11) : 321B - 321B
  • [50] Hydroxychloroquine reverses the drug resistance of leukemic K562/ADM cells by inhibiting autophagy
    Wang, Feifei
    Zhang, Zhewen
    Leung, Wing Ting
    Chen, Jing
    Yi, Juan
    Ying, Chunmei
    Yuan, Minmin
    Wang, Mingyan
    Zhang, Na
    Qiu, Xuemin
    Wang, Ling
    Wei, Hulai
    MOLECULAR MEDICINE REPORTS, 2019, 20 (04) : 3883 - 3892